Chinese Medicine for Patients With LCOVID-19 Symptoms | MicrobiomeTrials← Back to trialsNCT04924881
Chinese Medicine for Patients With LCOVID-19 Symptoms
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2021-07-02Est. Completion: 2022-10-03
Enrollment target: 68 participants Locations- The Chinese University of Hong Kong, Shatin, Hong Kong
Other microbiome trials you might be interested in
CancerImmune Checkpoint InhibitorsCOVID-19 VaccinationSurvival
COVICI-SURV is a nationwide, retrospective observational cohort study using the French national health data system (SNDS…
Paris, FranceEst. completion Dec 31, 2024
Post-Acute COVID-19 Syndrome
Background:
SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from an acute COVID-19 infection may …
Bethesda, United StatesEst. completion Jan 1, 2028